Haishi Hainuo Group is a national high-tech enterprise integrating biomedicine and medical devices research, production and sales. It has more than 3,000 employees. The group has conducted in-depth research and development with 6 academicians, 10 special experts, doctors and professors in related fields. Research and cooperation have jointly formed a R&D team of more than 300 people. The group's products involve biomedicine, medical devices, medical big data, intelligent robots, skin care products, daily necessities and other fields, including medical protective products, medical auxiliary materials, traditional Chinese medicine products, B-HA hyaluronic acid preparation series products, functional foods More than 100 categories including health products. Haishi Hainuo Group is the second largest band-tip brand in the country. Among them, cartoon band-tip stickers have set a precedent in the domestic band-tip industry. As a leading brand in China's trauma care industry, Haishi Hainuo has been conducting popular science education on trauma care for more than 20 years. In 2023, Haishi Hainuo proposed: "Three-step disinfection and bandage to prevent scars by trauma care", establishing standards for trauma care, and solving the social problem of Chinese people lacking common sense in trauma care. Haier Hainuo Group's sales network covers the world and is exported to more than 70 countries and regions around the world, and is highly favored by overseas consumers. In China, Haishi Hainuo serves more than 2,000 hospitals, 200,000 pharmacies, chain supermarkets and convenience stores, and has in-depth cooperation with top 100 chain pharmacies in the country such as Dasanlin, Hao Pharmacist, and Neptune Star. It has a variety of products on JD.com and Tmall Online platforms such as Pinduoduo are among the top in the entire network sales.
Hisea Group Co., Ltd.
Haishi Hainuo Group is a national high-tech enterprise integrating biomedicine and medical devices research, production and sales. It has more than 3,000 employees. The group has conducted in-depth research and development with 6 academicians, 10 special experts, doctors and professors in related fields. Research and cooperation have jointly formed a R&D team of more than 300 people. The group's products involve biomedicine, medical devices, medical big data, intelligent robots, skin care products, daily necessities and other fields, including medical protective products, medical auxiliary materials, traditional Chinese medicine products, B-HA hyaluronic acid preparation series products, functional foods More than 100 categories including health products. Haishi Hainuo Group is the second largest band-tip brand in the country. Among them, cartoon band-tip stickers have set a precedent in the domestic band-tip industry. As a leading brand in China's trauma care industry, Haishi Hainuo has been conducting popular science education on trauma care for more than 20 years. In 2023, Haishi Hainuo proposed: "Three-step disinfection and bandage to prevent scars by trauma care", establishing standards for trauma care, and solving the social problem of Chinese people lacking common sense in trauma care. Haier Hainuo Group's sales network covers the world and is exported to more than 70 countries and regions around the world, and is highly favored by overseas consumers. In China, Haishi Hainuo serves more than 2,000 hospitals, 200,000 pharmacies, chain supermarkets and convenience stores, and has in-depth cooperation with top 100 chain pharmacies in the country such as Dasanlin, Hao Pharmacist, and Neptune Star. It has a variety of products on JD.com and Tmall Online platforms such as Pinduoduo are among the top in the entire network sales.
Guangdong Iconas Biomedical Technology Co., Ltd.
David's test strips are one of the commonly used tools for women of childbearing age to test whether they are pregnant. They can accurately detect the peak levels of corpus lutein-producing hormone, allowing women to predict the time of conception or contraception. Guangdong Yiconnus Biomedical Technology Co., Ltd. was established in 2001 and is a wholly owned company in Canada. The company is located in Rongsheng Science and Technology Park, University Road, Shantou City, Guangdong Province, covering an area of 33 mu. It has modern, garden-based and GMP standard production plants, has strong scientific research capabilities, and has advanced production equipment; it is mainly engaged in biological and pharmaceutical technology The research, development and production of a series of high-tech biomedical products. The company has nearly ten years of experience in producing diagnostic reagent products, and its products are sold all over the world. The company has created "David" and "Quick Show" well-known domestic brands.
Guangdong Iconas Biomedical Technology Co., Ltd.
David's test strips are one of the commonly used tools for women of childbearing age to test whether they are pregnant. They can accurately detect the peak levels of corpus lutein-producing hormone, allowing women to predict the time of conception or contraception. Guangdong Yiconnus Biomedical Technology Co., Ltd. was established in 2001 and is a wholly owned company in Canada. The company is located in Rongsheng Science and Technology Park, University Road, Shantou City, Guangdong Province, covering an area of 33 mu. It has modern, garden-based and GMP standard production plants, has strong scientific research capabilities, and has advanced production equipment; it is mainly engaged in biological and pharmaceutical technology The research, development and production of a series of high-tech biomedical products. The company has nearly ten years of experience in producing diagnostic reagent products, and its products are sold all over the world. The company has created "David" and "Quick Show" well-known domestic brands.
Nantong East Biotechnology Co., Ltd.
Nantong Yishi Biotechnology Co., Ltd. established the Yijianshi brand in 2002, from the initial service to women of childbearing age to the current service scope to reproductive eugenics, prenatal screening, venereal disease testing, hepatitis testing, tumor marker testing, For drug testing and other services, the Ekins brand has always been committed to human health testing services. Ekins, be your health guardian! Nantong Yishi Biotechnology Co., Ltd. (hereinafter referred to as "Yish Biotechnology") was established in 1999. It is a national high-tech enterprise integrating biological raw material development, diagnostic reagent manufacturing, domestic and foreign trade, and services. The company has established Yishi Biological Research Institute and Beijing, Wuxi and Zhengzhou R&D centers, mainly conducting research and development of in vitro diagnostic reagents, nano-antibody, gene recombinant antigen, monoclonal antibody, polymerase chain reaction reagent (PCR), detection equipment and Production. The company is at the forefront of the industry in many fields such as family reproductive health testing, drug testing and drug abuse, infectious disease testing, and tumor diagnosis. Yishi Biologics has passed ISO9001, ISO14001, ISO45001, ISO13485 quality system certification, MDSAP system, and BRC system certification. In order to accelerate the industrial layout, Yishi Bioscience and Clinical Diagnostic Reagent Co., Ltd. has successively held Beijing Najie Diagnostic Reagent Co., Ltd. and Wuxi Ouplan Technology Co., Ltd. in 2021. Yishi Bio currently participates in the controlling stake in a total of 25 companies, forming a closed-loop industrial chain centered on Yishi Biotech, integrating raw material development, product research and development, production, testing, diagnosis, domestic and foreign trade, and services. Thanks to Yishi Bio's platform-based, standardized and cooperative R&D design management system, the company and its subsidiaries currently own 30 invention patents, 60 utility model patents, and 23 national patents under review. In the future, Yishi Biotech will continue to focus on life sciences, serve human health, and continue to provide you with more professional, more complete and better scientific diagnostic and testing solutions. We strive to become a leader in the field of family reproductive health testing and a major participant in China's drug control industry. We have become an important influential comprehensive service provider in clinical rapid immune testing, infectious disease testing, tumor diagnosis, etc. Empowered to create an international, advanced and rapidly developing IVD R&D, manufacturing and service platform.
Nantong East Biotechnology Co., Ltd.
Nantong Yishi Biotechnology Co., Ltd. established the Yijianshi brand in 2002, from the initial service to women of childbearing age to the current service scope to reproductive eugenics, prenatal screening, venereal disease testing, hepatitis testing, tumor marker testing, For drug testing and other services, the Ekins brand has always been committed to human health testing services. Ekins, be your health guardian! Nantong Yishi Biotechnology Co., Ltd. (hereinafter referred to as "Yish Biotechnology") was established in 1999. It is a national high-tech enterprise integrating biological raw material development, diagnostic reagent manufacturing, domestic and foreign trade, and services. The company has established Yishi Biological Research Institute and Beijing, Wuxi and Zhengzhou R&D centers, mainly conducting research and development of in vitro diagnostic reagents, nano-antibody, gene recombinant antigen, monoclonal antibody, polymerase chain reaction reagent (PCR), detection equipment and Production. The company is at the forefront of the industry in many fields such as family reproductive health testing, drug testing and drug abuse, infectious disease testing, and tumor diagnosis. Yishi Biologics has passed ISO9001, ISO14001, ISO45001, ISO13485 quality system certification, MDSAP system, and BRC system certification. In order to accelerate the industrial layout, Yishi Bioscience and Clinical Diagnostic Reagent Co., Ltd. has successively held Beijing Najie Diagnostic Reagent Co., Ltd. and Wuxi Ouplan Technology Co., Ltd. in 2021. Yishi Bio currently participates in the controlling stake in a total of 25 companies, forming a closed-loop industrial chain centered on Yishi Biotech, integrating raw material development, product research and development, production, testing, diagnosis, domestic and foreign trade, and services. Thanks to Yishi Bio's platform-based, standardized and cooperative R&D design management system, the company and its subsidiaries currently own 30 invention patents, 60 utility model patents, and 23 national patents under review. In the future, Yishi Biotech will continue to focus on life sciences, serve human health, and continue to provide you with more professional, more complete and better scientific diagnostic and testing solutions. We strive to become a leader in the field of family reproductive health testing and a major participant in China's drug control industry. We have become an important influential comprehensive service provider in clinical rapid immune testing, infectious disease testing, tumor diagnosis, etc. Empowered to create an international, advanced and rapidly developing IVD R&D, manufacturing and service platform.
Beijing Aikangtai Technology Co., Ltd.
Yumiao focuses on the digital diagnosis platform and intelligent Internet of Things industrialization in the field of home self-examination. It is currently starting from female reproductive health, especially those with difficult pregnancy and excellent pregnancy. It is a leading brand of digital reproductive health in China. Since its establishment in 2013, it has deeply cultivated the medical technology and intelligent Internet of Things platform of Fertility Awareness Method. Relying on the scientific research strength of its own core team of Tsinghua University and Peking University, it has combined the authenticity of female users at home and abroad. World Data, developed an iFAM algorithm and used it among more than 6 million users around the world. It has a biology cycle database of 1 billion female markers, and has also obtained Beijing Obstetrics and Gynecology Hospital, Aviation General Hospital, Jinxin Reproduction, Merck China, and Wanfu Biologics. Professional recognition from dozens of industry users such as Mom.com. The assisted reproductive digital therapy (diagnosis) technology provided by Yucheng Orange combines medicine and digital technology, with APP and intelligent in vitro diagnosis as the core, providing personalized intervention and treatment for difficult pregnancy groups. Through artificial intelligence technology and new home testing technology, we can accurately manage important indicators such as relevant signs and hormone levels, and provide users with subscription services such as ovulation monitoring, guidance on room attendance, lifestyle intervention, and professional content. The intelligent basic thermometer and intelligent ovulation test strips provide personalized and accurate services through the integrated linkage of software and hardware of the fertility APP, based on digital detection and big data analysis of many fertility indicators such as basic body temperature, ovulation test strips, cervical mucus, etc. , and provide visual management of data, locking shorter ovulation windows, helping consumers control their fertility. Yumiao is repositioning itself as a brand of digital reproductive health products and services, and will enter the broader digital home self-inspection track with multiple brands in the future.
Beijing Aikangtai Technology Co., Ltd.
Yumiao focuses on the digital diagnosis platform and intelligent Internet of Things industrialization in the field of home self-examination. It is currently starting from female reproductive health, especially those with difficult pregnancy and excellent pregnancy. It is a leading brand of digital reproductive health in China. Since its establishment in 2013, it has deeply cultivated the medical technology and intelligent Internet of Things platform of Fertility Awareness Method. Relying on the scientific research strength of its own core team of Tsinghua University and Peking University, it has combined the authenticity of female users at home and abroad. World Data, developed an iFAM algorithm and used it among more than 6 million users around the world. It has a biology cycle database of 1 billion female markers, and has also obtained Beijing Obstetrics and Gynecology Hospital, Aviation General Hospital, Jinxin Reproduction, Merck China, and Wanfu Biologics. Professional recognition from dozens of industry users such as Mom.com. The assisted reproductive digital therapy (diagnosis) technology provided by Yucheng Orange combines medicine and digital technology, with APP and intelligent in vitro diagnosis as the core, providing personalized intervention and treatment for difficult pregnancy groups. Through artificial intelligence technology and new home testing technology, we can accurately manage important indicators such as relevant signs and hormone levels, and provide users with subscription services such as ovulation monitoring, guidance on room attendance, lifestyle intervention, and professional content. The intelligent basic thermometer and intelligent ovulation test strips provide personalized and accurate services through the integrated linkage of software and hardware of the fertility APP, based on digital detection and big data analysis of many fertility indicators such as basic body temperature, ovulation test strips, cervical mucus, etc. , and provide visual management of data, locking shorter ovulation windows, helping consumers control their fertility. Yumiao is repositioning itself as a brand of digital reproductive health products and services, and will enter the broader digital home self-inspection track with multiple brands in the future.
Wuhan Jinghong Technology Co., Ltd.
Wuhan Jinghong Technology Co., Ltd. was established in 2005 with a registered capital of 59.6 million yuan and is a national high-tech enterprise. The company's main business covers three major areas: biological immune in vitro diagnosis, home medical electronics, and medical imaging. The products are mainly used for the detection of tumors, cardiovascular and cerebrovascular diseases, eugenics, and other aspects; bedside diagnosis of blood sugar, blood pressure, fetal heart rate, and electrocardiogram; and medical images such as digital B-ultrasound, DR. The company is headquartered in Wuhan Optics Valley Biocity, a national biological industry base, covering an area of 60 acres. The company is committed to "exploring the mysteries of life and serving the health of the public", and continues to focus on product and technological innovation in the fields of medical care, family health, public safety, etc. . It has 2 innovation fund projects of the Ministry of Science and Technology, 72 nationally authorized patents, 54 registration certificates for Class II and III medical devices, and 7 product CE certificates. The company has the right to operate self-operated import and export, Internet B2C sales platform for drugs and medical devices. The products are promoted and used in OTC pharmacies, hospitals at all levels, and disease control centers, covering major cities across the country and remote areas such as Xinjiang, Tibet, and Inner Mongolia. The sales channels are mature. Stablize. Under the guidance of the national "Belt and Road" policy, we will continue to expand the international market and export to the Americas, Europe, the Middle East, Southeast Asia and Africa. The company focuses on the product development strategy of "two highs and one long", namely high-tech content, high market capacity and long life cycle, and is deeply engaged in the field of in vitro diagnosis. The company is committed to becoming a leader in the domestic in vitro diagnostic industry (IVD) and realizing the company's industrial dream and Chinese dream.
Wuhan Jinghong Technology Co., Ltd.
Wuhan Jinghong Technology Co., Ltd. was established in 2005 with a registered capital of 59.6 million yuan and is a national high-tech enterprise. The company's main business covers three major areas: biological immune in vitro diagnosis, home medical electronics, and medical imaging. The products are mainly used for the detection of tumors, cardiovascular and cerebrovascular diseases, eugenics, and other aspects; bedside diagnosis of blood sugar, blood pressure, fetal heart rate, and electrocardiogram; and medical images such as digital B-ultrasound, DR. The company is headquartered in Wuhan Optics Valley Biocity, a national biological industry base, covering an area of 60 acres. The company is committed to "exploring the mysteries of life and serving the health of the public", and continues to focus on product and technological innovation in the fields of medical care, family health, public safety, etc. . It has 2 innovation fund projects of the Ministry of Science and Technology, 72 nationally authorized patents, 54 registration certificates for Class II and III medical devices, and 7 product CE certificates. The company has the right to operate self-operated import and export, Internet B2C sales platform for drugs and medical devices. The products are promoted and used in OTC pharmacies, hospitals at all levels, and disease control centers, covering major cities across the country and remote areas such as Xinjiang, Tibet, and Inner Mongolia. The sales channels are mature. Stablize. Under the guidance of the national "Belt and Road" policy, we will continue to expand the international market and export to the Americas, Europe, the Middle East, Southeast Asia and Africa. The company focuses on the product development strategy of "two highs and one long", namely high-tech content, high market capacity and long life cycle, and is deeply engaged in the field of in vitro diagnosis. The company is committed to becoming a leader in the domestic in vitro diagnostic industry (IVD) and realizing the company's industrial dream and Chinese dream.
Abbott Diagnostic Products (Shanghai) Co., Ltd.
Corillan is a brand under Swiss Precision Diagnostics GmbH (SPD), a company that leads in researching, designing, producing and supplying advanced consumer diagnostic products. Kelilan has always been committed to providing advanced technology to all women, whether it is a woman who is preparing for pregnancy or who thinks she may be pregnant, Kelilan will provide you with accurate, quick and clear answers. Since 1985, Kelilan developed a home early pregnancy test pen with 30 minutes of results, it has been committed to helping women so that they can accurately, quickly and clearly obtain "Am I pregnant?" or "When did I? Answers to questions such as conception?” Kelilan's product range includes early pregnancy test pens and ovulation test pens. Each product was developed with the help and feedback of about 5,000 women, and about 30,000 quality checks will be conducted before it is put on the market. After 35 years of research and innovation, Kelilan has always been committed to the same goal: to improve the way women manage their childbearing health.
Abbott Diagnostic Products (Shanghai) Co., Ltd.
Corillan is a brand under Swiss Precision Diagnostics GmbH (SPD), a company that leads in researching, designing, producing and supplying advanced consumer diagnostic products. Kelilan has always been committed to providing advanced technology to all women, whether it is a woman who is preparing for pregnancy or who thinks she may be pregnant, Kelilan will provide you with accurate, quick and clear answers. Since 1985, Kelilan developed a home early pregnancy test pen with 30 minutes of results, it has been committed to helping women so that they can accurately, quickly and clearly obtain "Am I pregnant?" or "When did I? Answers to questions such as conception?” Kelilan's product range includes early pregnancy test pens and ovulation test pens. Each product was developed with the help and feedback of about 5,000 women, and about 30,000 quality checks will be conducted before it is put on the market. After 35 years of research and innovation, Kelilan has always been committed to the same goal: to improve the way women manage their childbearing health.
As an inclusive brand, "Xiuer" aims to provide considerate and affordable products and services to ordinary people. "Xiuer" has more than 20 years of operation experience in the market, has a wide audience, and has a good reputation. It is similar. The products are sold well in more than 100 countries around the world. Guangzhou Wanfu Health Technology Co., Ltd. (referred to as Wanfu Health) is a holding subsidiary of Wanfu Biotech (stock code 300482), one of the leading companies in the domestic POCT (instant detection) industry. Wanfu Bio has been deeply engaged in the professional medical market and has a "national and local joint engineering laboratory for self-examination rapid diagnosis". By constantly innovating business models and product services, Wanfu Health has opened up all aspects of products, data and services, and is committed to applying medical-grade products to non-professional personal and family health fields, with a vision to become a new generation of family health management platform. Up to now, a total of 19 patents have been applied for, including 17 authorized patents; 23 software copyrights have been applied for, including 23 authorized; and 45 copyrights have been owned.
Wondfo Biotech Co., Ltd.
As an inclusive brand, "Xiuer" aims to provide considerate and affordable products and services to ordinary people. "Xiuer" has more than 20 years of operation experience in the market, has a wide audience, and has a good reputation. It is similar. The products are sold well in more than 100 countries around the world. Guangzhou Wanfu Health Technology Co., Ltd. (referred to as Wanfu Health) is a holding subsidiary of Wanfu Biotech (stock code 300482), one of the leading companies in the domestic POCT (instant detection) industry. Wanfu Bio has been deeply engaged in the professional medical market and has a "national and local joint engineering laboratory for self-examination rapid diagnosis". By constantly innovating business models and product services, Wanfu Health has opened up all aspects of products, data and services, and is committed to applying medical-grade products to non-professional personal and family health fields, with a vision to become a new generation of family health management platform. Up to now, a total of 19 patents have been applied for, including 17 authorized patents; 23 software copyrights have been applied for, including 23 authorized; and 45 copyrights have been owned.
WanHua Puman Bioengineering Co., Ltd.
Wanhua Puman Bioengineering Company is a wholly-owned American enterprise established in Beijing in 1993 with the approval of the Ministry of Economic and Trade and the State Administration of Industry and Commerce. It is mainly engaged in the research, development and production of bioengineering diagnostic products. It has a Shenyang Branch and Chengdu Branch. The company, Shanghai branch, Guangdong office and other branches. Wanhua Company became a foreign-funded enterprise that introduced diagnostic reagents for early pregnancy monoclonal antibodies in 1993. With the company's good development, by 1996, the company's development of products increased to four major categories: early pregnancy, ovulation, stool hiccups, and drugs. In order to align with advanced international enterprises, the company passed the ISO9001 quality system certification in 2000 and the CE certification in European quality system in 2002. In order to strengthen the quality management of the enterprise, the company organizes two internal audits and one external audit every year. Due to domestic and foreign market demand, especially in line with international standards after joining the WTO, the company has passed the GMP certification work in February 2006 according to the relevant regulations on the management of national pharmaceutical manufacturing enterprises.
WanHua Puman Bioengineering Co., Ltd.
Wanhua Puman Bioengineering Company is a wholly-owned American enterprise established in Beijing in 1993 with the approval of the Ministry of Economic and Trade and the State Administration of Industry and Commerce. It is mainly engaged in the research, development and production of bioengineering diagnostic products. It has a Shenyang Branch and Chengdu Branch. The company, Shanghai branch, Guangdong office and other branches. Wanhua Company became a foreign-funded enterprise that introduced diagnostic reagents for early pregnancy monoclonal antibodies in 1993. With the company's good development, by 1996, the company's development of products increased to four major categories: early pregnancy, ovulation, stool hiccups, and drugs. In order to align with advanced international enterprises, the company passed the ISO9001 quality system certification in 2000 and the CE certification in European quality system in 2002. In order to strengthen the quality management of the enterprise, the company organizes two internal audits and one external audit every year. Due to domestic and foreign market demand, especially in line with international standards after joining the WTO, the company has passed the GMP certification work in February 2006 according to the relevant regulations on the management of national pharmaceutical manufacturing enterprises.
Shenzhen Contec Biotechnology Co., Ltd.
Shenzhen Kangnaig Biotechnology Co., Ltd. was founded in May 2000 and mainly produces and sells in vitro diagnostic reagents. After more than ten years of struggle, the company has developed into a R&D, production and sales complex enterprise. The company has a laboratory of 1,000 square meters, and a 100,000-level clean workshop of 400 square meters and a 10,000-level clean workshop of 10000-level clean workshop of 100 square meters. The company has various advanced instruments and equipment that meet R&D, production and quality inspection, and has passed the ISO13485 quality system certification and has CE 98/79/EC certificate.
Shenzhen Contec Biotechnology Co., Ltd.
Shenzhen Kangnaig Biotechnology Co., Ltd. was founded in May 2000 and mainly produces and sells in vitro diagnostic reagents. After more than ten years of struggle, the company has developed into a R&D, production and sales complex enterprise. The company has a laboratory of 1,000 square meters, and a 100,000-level clean workshop of 400 square meters and a 10,000-level clean workshop of 10000-level clean workshop of 100 square meters. The company has various advanced instruments and equipment that meet R&D, production and quality inspection, and has passed the ISO13485 quality system certification and has CE 98/79/EC certificate.
China Resources Pharmaceutical Holdings Co., Ltd.
Yuting is a brand under China Resources Zizhu Pharmaceutical, a leading domestic emergency contraception brand. It is a large pharmaceutical company focusing on the development and production of family planning drugs. It has successively launched a series of products such as contraceptive pills, ovulation test strips, early pregnancy test strips, condoms, etc. The company's leading product, the emergency contraceptive pill "Yuting" and the anti-premature pregnancy pill "mifepristone", have received good domestic market response after it was launched, and it has been registered in more than 20 countries or regions.
China Resources Pharmaceutical Holdings Co., Ltd.
Yuting is a brand under China Resources Zizhu Pharmaceutical, a leading domestic emergency contraception brand. It is a large pharmaceutical company focusing on the development and production of family planning drugs. It has successively launched a series of products such as contraceptive pills, ovulation test strips, early pregnancy test strips, condoms, etc. The company's leading product, the emergency contraceptive pill "Yuting" and the anti-premature pregnancy pill "mifepristone", have received good domestic market response after it was launched, and it has been registered in more than 20 countries or regions.
First Response Gold is a premium line of pregnancy tests known for its advanced technology and high accuracy.
Church & Dwight
First Response Gold is a premium line of pregnancy tests known for its advanced technology and high accuracy.
Swiss Precision Diagnostics
This brand offers pregnancy tests that are specifically designed to be used by couples trying to conceive, providing clear and accurate results.
Swiss Precision Diagnostics
This brand offers pregnancy tests that are specifically designed to be used by couples trying to conceive, providing clear and accurate results.
Swiss Precision Diagnostics
ConceiveEasy is a brand that focuses on fertility support, including pregnancy tests that are user-friendly and accurate.
Swiss Precision Diagnostics
ConceiveEasy is a brand that focuses on fertility support, including pregnancy tests that are user-friendly and accurate.
Swiss Precision Diagnostics
TestSure offers affordable and reliable pregnancy tests, designed to be accessible to a wide range of users.
Swiss Precision Diagnostics
TestSure offers affordable and reliable pregnancy tests, designed to be accessible to a wide range of users.
Swiss Precision Diagnostics
FirstSign is a brand focused on early detection of pregnancy, offering tests that can detect hCG levels earlier than many competitors.
Swiss Precision Diagnostics
FirstSign is a brand focused on early detection of pregnancy, offering tests that can detect hCG levels earlier than many competitors.
Swiss Precision Diagnostics
Conceive Plus specializes in fertility products, including pregnancy tests designed to help couples trying to conceive.
Swiss Precision Diagnostics
Conceive Plus specializes in fertility products, including pregnancy tests designed to help couples trying to conceive.
This brand offers digital pregnancy tests that provide clear and easy-to-read results, enhancing user experience.
Church & Dwight
This brand offers digital pregnancy tests that provide clear and easy-to-read results, enhancing user experience.
EPT is a pioneering brand in the pregnancy test industry, recognized for its innovative and reliable testing methods.
Church & Dwight
EPT is a pioneering brand in the pregnancy test industry, recognized for its innovative and reliable testing methods.
First Response is a trusted name in home health testing, including pregnancy tests that are known for their high accuracy and reliability.
Church & Dwight
First Response is a trusted name in home health testing, including pregnancy tests that are known for their high accuracy and reliability.
Alere Inc. (now part of Becton, Dickinson and Company)
Clearblue Digital Pregnancy Test is a widely recognized brand known for its clear and easy-to-read digital results, enhancing user confidence in the outcome.
Alere Inc. (now part of Becton, Dickinson and Company)
Clearblue Digital Pregnancy Test is a widely recognized brand known for its clear and easy-to-read digital results, enhancing user confidence in the outcome.
